Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Cardiopulmonary bypass flow rate: a risk factor for hyperlactatemia after surgical repair of secundum atrial septal defect in children.
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Peripheral circadian misalignment: contributor to systemic insulin resistance and potential intervention to improve bariatric surgical outcomes.
Gastroscopes
Squamous cell carcinoma of the esophagus: treat with how many modalities?
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Squamous cell carcinoma of the esophagus: treat with how many modalities?
Squamous cell carcinoma of the esophagus: treat with how many modalities? Semin Oncol. 2009 Dec; 36(6):493-7.
View in:
PubMed
subject areas
Carcinoma, Squamous Cell
Chemotherapy, Adjuvant
Esophageal Neoplasms
Esophagectomy
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Positron-Emission Tomography
Radiotherapy, Adjuvant
authors with profiles
Matthew Koshy